
This episode explores the financial aspects of diabetes research and the involvement of investors and shareholders in the biotech industry.
Send us Fan Mail What does the stock market have to do with curing type 1 diabetes? Actually...a lot. In this episode of the Diabetes Nerd Podcast, my friend Julia Flaherty joins me to pull back the curtain on the business side of diabetes research. We talk about how biotech companies raise money, why investors get excited about clinical trial results, what happens when a company gets acquired, and why so many people living with T1D are becoming shareholders themselves. If you've ever wondere...
Explore listener stats, chart rankings, contacts and more on the Diabetes Nerd podcast page.